Fingerprint
Dive into the research topics of 'Cost-effectiveness of abiraterone versus docetaxel in the treatment of metastatic hormone naïve prostate cancer'. Together they form a unique fingerprint.- Sort by
- Weight
- Alphabetically
Cost-effectiveness of abiraterone versus docetaxel in the treatment of metastatic hormone naïve prostate cancer
Chethan Ramamurthy, Elizabeth A. Handorf, Andres F. Correa, J. Robert Beck, Daniel M. Geynisman
Research output: Contribution to journal › Article › peer-review
11
Scopus
citations